MYLARI; Banavara L.
Patent Applications and Registrations
Patent applications and USPTO patent grants for MYLARI; Banavara L..The latest application filed is for "aldose reductase inhibitors and uses thereof".
Company Profile
6.38.64
- MYLARI; Banavara L. - East Lyme CT
- MYLARI; Banavara L. - Lutz FL
- Mylari; Banavara L. - Waterford CT
- Mylari; Banavara L. - US
- Mylari; Banavara L. - Waterfrod CT
- Mylari, Banavara L - Waterford CT
Patent Activity
| Patent | Date |
|---|---|
| Aldose Reductase Inhibitors And Uses Thereof App 20200289512 - WASMUTH; Andrew ; et al. | 2020-09-17 |
| Aldose Reductase Inhibitors And Uses Thereof App 20200268755 - WASMUTH; Andrew ; et al. | 2020-08-27 |
| Aldose reductase inhibitors and uses thereof Grant 10,639,306 - Wasmuth , et al. | 2020-05-05 |
| Water Soluble Salts Of Aldose Reductase Inhibitors For Treatment Of Diabetic Complications App 20190263825 - MYLARI; Banavara L. | 2019-08-29 |
| Aldose Reductase Inhibitors And Uses Thereof App 20190201400 - WASMUTH; Andrew ; et al. | 2019-07-04 |
| Aldose Reductase Inhibitors And Uses Thereof App 20180271865 - WASMUTH; Andrew ; et al. | 2018-09-27 |
| Aldose reductase inhibitors and uses thereof Grant 10,052,324 - Wasmuth , et al. August 21, 2 | 2018-08-21 |
| Anti-inflammatory And Antidiabetic Agents App 20170368079 - Mylari; Banavara L. | 2017-12-28 |
| Water Soluble Salts Of Aldose Reductase Inhibitors For Treatment Of Diabetic Complications App 20170362237 - Mylari; Banavara L. | 2017-12-21 |
| Aldose Reductase Inhibitors And Uses Thereof App 20170319584 - WASMUTH; Andrew ; et al. | 2017-11-09 |
| Aldose Reductase Inhibitors And Uses Thereof App 20170216291 - WASMUTH; Andrew ; et al. | 2017-08-03 |
| Aldose Reductase Inhibitors And Uses Thereof App 20170216292 - WASMUTH; Andrew ; et al. | 2017-08-03 |
| Aldose reductase inhibitors and uses thereof Grant 9,650,383 - Wasmuth , et al. May 16, 2 | 2017-05-16 |
| Compositions and Methods Relating to Ionic Salts of Peptides App 20170096449 - Mathias; Gary ; et al. | 2017-04-06 |
| Compositions and methods relating to ionic salts of peptides Grant 9,505,709 - Mathias , et al. November 29, 2 | 2016-11-29 |
| Tri-salt form of metformin Grant 9,382,187 - Mylari , et al. July 5, 2 | 2016-07-05 |
| Compositions and Methods Relating to Ionic Salts of Peptides App 20160107985 - Mathias; Gary ; et al. | 2016-04-21 |
| Lipid-lowering antidiabetic agent Grant 9,216,951 - Mylari , et al. December 22, 2 | 2015-12-22 |
| Tri-Salt Form of Metformin App 20150197475 - Mylari; Banavara L. ; et al. | 2015-07-16 |
| Lipid-lowering antidiabetic agent Grant 9,012,507 - Mylari , et al. April 21, 2 | 2015-04-21 |
| Aldose Reductase Inhibitors And Uses Thereof App 20150072989 - WASMUTH; Andrew ; et al. | 2015-03-12 |
| Lipid-Lowering Antidiabetic Agent App 20150051284 - Mylari; Banavara L. ; et al. | 2015-02-19 |
| Tri-salt form of metformin Grant 8,933,124 - Mylari , et al. January 13, 2 | 2015-01-13 |
| Aldose reductase inhibitors and uses thereof Grant 8,916,563 - Wasmuth , et al. December 23, 2 | 2014-12-23 |
| Ursolic Acid Salts For Treating Diabetes And Obesity App 20140364500 - Mylari; Banavara L. ; et al. | 2014-12-11 |
| Lipid-lowering antidiabetic agent Grant 8,901,107 - Mylari , et al. December 2, 2 | 2014-12-02 |
| Anti-inflammatory And Antidiabetic Agents App 20140323444 - Mylari; Banavara L. | 2014-10-30 |
| Metformin derivatives for treating diabetes and diabetes complications Grant 8,853,259 - Mylari October 7, 2 | 2014-10-07 |
| Tri-Salt Form of Metformin App 20140249221 - Mylari; Banavara L. ; et al. | 2014-09-04 |
| Water Soluble Salts Of Aldose Reductase Inhibitors For Treatment Of Diabetic Complications App 20140228319 - Mylari; Banavara L. | 2014-08-14 |
| Metformin Derivatives For Treating Diabetes And Diabetes Complications App 20140221467 - Mylari; Banavara L. | 2014-08-07 |
| Tri-salt form of metformin Grant 8,765,811 - Mylari , et al. July 1, 2 | 2014-07-01 |
| Salt Forms Of Fatty Acids For The Treatment Of Dry Eye App 20140148464 - Mylari; Banavara L. ; et al. | 2014-05-29 |
| Lipid-lowering Antidiabetic Agent App 20140107360 - Mylari; Banavara L. ; et al. | 2014-04-17 |
| Ursolic Acid Salts For Treating Diabetes And Obesity App 20140024708 - Mylari; Banavara L. ; et al. | 2014-01-23 |
| Tri-salt Form Of Metformin App 20140018419 - MYLARI; Banavara L. ; et al. | 2014-01-16 |
| Diamine And Meglumine Salt Forms Of Fatty Acids App 20140011814 - MYLARI; Banavara L. ; et al. | 2014-01-09 |
| Lipid-lowering Antidiabetic Agent App 20130281535 - Mylari; Banavara L. ; et al. | 2013-10-24 |
| Metformin Salts Of Salicylic Acid And It Congeners App 20130252926 - Mylari; Banavara L. | 2013-09-26 |
| Aldose Reductase Inhibitors And Uses Thereof App 20130225592 - WASMUTH; Andrew ; et al. | 2013-08-29 |
| Metformin salts of salicylic acid and its congeners Grant 8,440,723 - Mylari May 14, 2 | 2013-05-14 |
| Metformin Salts of Salicylic Acid and Its Congeners App 20120289485 - Mylari; Banavara L. | 2012-11-15 |
| Lipid-lowering Antidiabetic Agent App 20120178813 - Mylari; Banavara L. ; et al. | 2012-07-12 |
| Antidiabetic agent for control of diabetic hyperglycemia and diabetic complications Grant 7,973,073 - Mylari , et al. July 5, 2 | 2011-07-05 |
| Pyridazinone aldose reductase inhibitors Grant 7,572,910 - Mylari August 11, 2 | 2009-08-11 |
| Antidiabetic agent for control of diabetic hyperglycemia and diabetic complications App 20070293562 - Mylari; Banavara L. ; et al. | 2007-12-20 |
| Sorbitol dehrydrogenase inhibitors Grant 6,936,600 - Chu-Moyer , et al. August 30, 2 | 2005-08-30 |
| Pyridazinone aldose reductase inhibitors App 20050113381 - Mylari, Banavara L. | 2005-05-26 |
| Triazine compounds useful as sorbitol dehydrogenase inhibitors Grant 6,894,047 - Mylari May 17, 2 | 2005-05-17 |
| Therapies for tissue damage resulting from ischemia Grant 6,872,722 - Mylari March 29, 2 | 2005-03-29 |
| Sorbitol dehydrogenase inhibitors Grant 6,869,943 - Chu-Moyer , et al. March 22, 2 | 2005-03-22 |
| Pyridazinone aldose reductase inhibitors Grant 6,849,629 - Mylari February 1, 2 | 2005-02-01 |
| Sorbitol dehydrogenase inhibitors App 20050020578 - Chu-Moyer, Margaret Y. ; et al. | 2005-01-27 |
| Therapies Relating To Combinations Of Aldose Reductase Inhibitors And Cyclooxygenase-2 Inhibitors App 20050004124 - Mylari, Banavara L. | 2005-01-06 |
| Therapies relating to combinations of aldose reductase inhibitors and cyclooxygenase-2 App 20040198740 - Mylari, Banavara L. | 2004-10-07 |
| Sulfonyl pyridazinone compounds useful as aldose reductase inhibitors Grant 6,730,674 - Martin , et al. May 4, 2 | 2004-05-04 |
| Sorbitol dehydrogenase inhibitors App 20040077671 - Chu-Moyer, Margaret Y. ; et al. | 2004-04-22 |
| Combination of gaba agonists and aldose reductase Inhibitors Grant 6,720,348 - Mylari April 13, 2 | 2004-04-13 |
| Sorbitol dehydrogenase inhibitors Grant 6,660,740 - Chu-Moyer , et al. December 9, 2 | 2003-12-09 |
| Salts of zopolrestat App 20030212072 - Mylari, Banavara L. | 2003-11-13 |
| Combination of statins and sorbitol dehydrogenase inhibitors App 20030186994 - Mylari, Banavara L. | 2003-10-02 |
| Pyridazinone aldose reductase inhibitors App 20030162784 - Mylari, Banavara L. | 2003-08-28 |
| Sorbitol dehydrogenase inhibitors Grant 6,602,875 - Chu-Moyer , et al. August 5, 2 | 2003-08-05 |
| Three dimensional crystal structure of human sorbitol dehydrogenase and uses thereof App 20030119160 - Mylari, Banavara L. ; et al. | 2003-06-26 |
| Combinations of aldose reductase inhibitors and selective cyclooxygenase-2 inhibitors Grant 6,555,540 - Mylari April 29, 2 | 2003-04-29 |
| Sorbitol dehydrogenase inhibitors App 20030065179 - Chu-Moyer, Margaret Y. ; et al. | 2003-04-03 |
| Combination of aldose reductase inhibitors and angiotensin-II antagonists for the treatment of diabetic nephropathy App 20030050301 - Mylari, Banavara L. | 2003-03-13 |
| Therapies for tissue damage resulting from ischemia App 20030008871 - Mylari, Banavara L. | 2003-01-09 |
| Novel triazine compounds useful as sorbitol dehydrogenase inhibitors App 20030004166 - Mylari, Banavara L. | 2003-01-02 |
| Sulfonyl pyridazinone compounds useful as aldose reductase inhibitors App 20030004139 - Martin, William H. ; et al. | 2003-01-02 |
| Pyridazinone aldose reductase inhibitors App 20020143017 - Mylari, Banavara L. | 2002-10-03 |
| Combination of gaba agonists and sorbitol dehydrogenase inhibitors App 20020091128 - Mylari, Banavara L. | 2002-07-11 |
| Combination of GABA agonists and aldose reductase inhibitors App 20020077319 - Mylari, Banavara L. | 2002-06-20 |
| Combination of aldose reductase inhibitors and antihypertensive agents for the treatment of diabetic complications App 20020068740 - Mylari, Banavara L. | 2002-06-06 |
| Compositions and treatment for diabetic complications App 20020061918 - Mylari, Banavara L. | 2002-05-23 |
| Salts of zopolrestat App 20010056095 - Mylari, Banavara L. | 2001-12-27 |
| Compounds for treating and preventing diabetic complications Grant 6,294,538 - Mylari September 25, 2 | 2001-09-25 |
| Substituted pyrimidines for control of diabetic complications Grant 5,866,578 - Mylari , et al. February 2, 1 | 1999-02-02 |
| Substituted pyridmidines for control of diabetic complications Grant 5,728,704 - Mylari , et al. March 17, 1 | 1998-03-17 |
| Pyrroloquinoline and pyrrolophenothiazine carboxamides and related compounds Grant 5,624,929 - Mylari , et al. April 29, 1 | 1997-04-29 |
| Substituted oxoophthalazinyl acetic acids and analogs thereof Grant 5,304,557 - Mylari April 19, 1 | 1994-04-19 |
| Process and intermediates for the preparation of oxophthalazinyl acetic acids and analogs thereof Grant 4,954,629 - Mylari , et al. September 4, 1 | 1990-09-04 |
| Heterocyclic oxophthalazinyl acetic acids Grant 4,939,140 - Larson , et al. July 3, 1 | 1990-07-03 |
| Preparation of 2(aryl)-as-triazine-3,5(2H,4H)-dione coccidiostats Grant 3,883,528 - Mylari May 13, 1 | 1975-05-13 |
| Thermal rearrangement of 3-aryloxytriazine-5(4H)-ones Grant 3,883,525 - Mylari May 13, 1 | 1975-05-13 |
| Preparation of 2-aryl-as-triazine-3,5 (2H,4H)-diones Grant 3,882,115 - Mylari May 6, 1 | 1975-05-06 |
| Sulfenylation Of N-arylheterocyclic Compounds Grant 3,852,289 - Mylari , et al. December 3, 1 | 1974-12-03 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 